StockNews.AI
ICL
StockNews.AI
6 days

Israel Corp. Reports Results for Second Quarter of 2025

1. ILCO reported a Q2 profit share decline in ICL from $50M to $40M. 2. ILCO holds a 44% stake in ICL, impacting its financial performance. 3. ILCO's total assets as of June 30, 2025, are $4.07B. 4. Net cash at ILCO increased slightly to $26M from $21M in Q1 2025. 5. ILCO plans to focus investments in food, agriculture, and healthcare sectors.

Earnings
+1.66%Current Return
VS
+0.22%S&P 500
$6.0208/13 12:25 PM EDTEvent Start
$6.1208/14 07:03 PM EDTLatest Updated
7m saved
Insight
Article

FAQ

Why Bearish?

The decline in profit contribution from ICL may signal weakening operational performance, potentially leading to investor concerns similar to past instances when parent firms reported lower earnings from major subsidiaries.

How important is it?

The financial performance and stakes of ILCO in ICL are crucial due to the significant percentage ownership and influence on overall financial health.

Why Short Term?

Immediate investor reactions to quarterly results typically influence market price in the following trading days.

Related Companies

ICLILCOAKVA
, /PRNewswire/ -- Israel Corporation Ltd. (TASE: ILCO) ("ILCO") announced today its second quarter results for the period ending June 30, 2025. Selected Financial Figures for the Second Quarter 2025: $m Q2/25 Q2/24 ILCO share in ICL profit 40 50 ILCO share in Prodalim profit 2 - Amortization of excess cost in held companies (2) (1) Financing, G&A and other at ILCO headquarter level 2 (1) Tax income of ILCO Headquarters 1 - Net profit to company's shareholders 43 48 Liquidity at the ILCO Headquarters Level[1] As of June 30, 2025, total financial liabilities were $715 million, and investments in liquid assets amounted to $739 million of which $8 million are pledged deposits. Net cash1 as of June 30, 2025, totaled $26 million. The net cash includes the fair value of derivatives transactions, which decreases the economic value of the financial liabilities by $2 million. As of March 31, 2025, the net cash was $21 million. Additional updates On March 5, 2025, ILCO completed the investment agreement with Prodalim Investments Ltd, ("Prodalim"), dated January 21, 2025, after the completion of the transaction, ILCO holds approximately 27.5% of Prodalim's share capital, on a fully diluted basis. Prodalim is a private company, incorporated in Israel, which is engaged in creating natural solutions for various industries. Its products include concentrates, flavors and fragrances, beverage bases and other natural functional ingredients. In addition, Prodalim is developing innovative activities focused on the emerging world of the de-alcoholization of alcoholic beverages* On March 27, 2025, ILCO Board of Directors decided on distribution of dividend at the sum of $15m, this in accordance with the company's dividend policy announced in January 2023. The record date was April 9, 2025, and the payment date was April 21, 2025. ILCO financial results of ILCO are mainly affected by the results of its investees. For more details see detailed financial report. ILCO Total Assets, Net $m 30/06/2025 Assets ICL (~567m shares, market value) 3,883 Prodalim (cost) 118 AKVA Group (~6.6m shares, market value) 54 Other[2] 15 Total Assets 4,070 ILCO's Net Cash 26 Total Assets, net 4,096 About Israel Corporation Israel Corporation Ltd. (TASE: ILCO) ("ILCO") is a reputable public investment company, which owns and invests in high quality companies with established managements and go-to markets. In November 2019, ILCO announced its updated strategy, ILCO plans to expand its portfolio through new investments over the next few years. ILCO plans to focus mainly on the food (inc. tech), agriculture (inc. tech), healthcare and industry 4.0 sectors. For more details please see the following link to ILCO updated Strategy Presentation  ILCO strives to generate return on its investment through active board participations and its operational and managerial expertise. ILCO current core holdings include c.44% stake in ICL Group (NYSE:ICL, TASE:ICL), c.18% stake in AKVA Group (OB:AKVA) and c.27.5% in Prodalim (on a fully diluted basis). ILCO is publicly traded on the Tel Aviv Stock Exchange under the ticker ILCO and is included in the TA-35 Index. For further information on ILCO, see ILCO's publicly available filings, which can be found on the Tel Aviv Stock Exchange website at http://maya.tase.co.il. Please also see ILCO company website http://www.israelcorp.com for additional information. Convenience Translation The financial information found in this press release is an English summary based on the original Hebrew financial statements and is solely for the convenience of the reader. The binding version is the original in Hebrew. Forward Looking Statements This press release may contain forward-looking statements, which may not materialize and are subject to risks and uncertainties that are not under the control of ILCO, which may cause actual results to differ materially from those contained in the disclosures. Investor Relations ContactsIdan HizkiVice President, Business DevelopmentTel: +972 3 684 4500[email protected] [1] Israel Corp and its wholly owned and controlled headquarter companies. [2] Includes 1.983m shares in Nordic Aqua Partners (OB:NOAP). SOURCE Israel Corporation Ltd. WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News